BORA PHARMACEUTICALS LTD (6472) — Cash Flow Reinvestment Rate
BORA PHARMACEUTICALS LTD (6472) has a Cash Flow Reinvestment Rate of 0.17x as of December 2025, reinvesting NT$204.93 Million (capex NT$204.93 Million ) from operating cash flow of NT$1.17 Billion. Explore 6472 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BORA PHARMACEUTICALS LTD Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for BORA PHARMACEUTICALS LTD across 7 annual periods. Also explore BORA PHARMACEUTICALS LTD total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year capital reinvestment analysis for BORA PHARMACEUTICALS LTD. For live market cap and broader valuation context, see how much is BORA PHARMACEUTICALS LTD worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | NT$953.00 Million | NT$4.24 Billion | NT$928.67 Million | ▼ -80.2% |
| 2024 | 1.13x | NT$1.11 Billion | NT$980.81 Million | NT$687.05 Million | ▲ +254.9% |
| 2023 | 0.32x | NT$1.47 Billion | NT$4.61 Billion | NT$1.43 Billion | ▲ +22.3% |
| 2022 | 0.26x | NT$524.20 Million | NT$2.01 Billion | NT$200.22 Million | ▼ -11.3% |
| 2021 | 0.29x | NT$363.58 Million | NT$1.24 Billion | NT$363.58 Million | ▼ -65.6% |
| 2020 | 0.86x | NT$152.09 Million | NT$177.79 Million | NT$152.09 Million | ▼ -71.6% |
| 2019 | 3.01x | NT$697.33 Million | NT$231.77 Million | NT$697.33 Million | — |